Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Lupin

    Tag: Lupin

    You Searched For "Lupin"
    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Medical Dialogues Bureau13 April 2020 7:30 AM GMT
    Mumbai: Lupin Limited has announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin's...
    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Medical Dialogues Bureau13 April 2020 5:32 AM GMT
    Mumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after the closure of the U.S. FDA inspection of its...
    Lupin launches Mycophenolic Acid Delayed-Release Tablets USP

    Lupin launches Mycophenolic Acid Delayed-Release Tablets USP

    Medical Dialogues Bureau7 April 2020 7:42 AM GMT
    Mumbai, Baltimore: Pharma major Lupin Limited (Lupin) announced the launch of Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg....
    Lupin gets USFDA EIR for Aurangabad Facility

    Lupin gets USFDA EIR for Aurangabad Facility

    Medical Dialogues Bureau4 April 2020 8:08 AM GMT
    Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Lupin gets USFDA EIR for Inhalation Research Center, Florida

    Medical Dialogues Bureau30 March 2020 9:34 AM GMT
    Coral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Mylan, Lupin Announce Positive CHMP Opinion for Nepexto

    Medical Dialogues Bureau29 March 2020 8:02 AM GMT
    Hertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs

    Medical Dialogues Bureau27 March 2020 4:00 AM GMT
    Mumbai: Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....
    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

    Medical Dialogues Bureau23 March 2020 4:00 AM GMT
    It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13...
    Lupin Receives International Sustainability Rating System (ISRS) Certification

    Lupin Receives International Sustainability Rating System (ISRS) Certification

    Medical Dialogues Bureau13 March 2020 6:50 AM GMT
    Mumbai: Pharma major Lupin Limited has announced that the Company has received certification for International Sustainability Rating System (ISRS),...
    Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

    Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

    Medical Dialogues Bureau11 March 2020 10:41 AM GMT
    Mumbai: Lupin Limited won the coveted India Pharma Leader Award at the India Pharma 2020 and India Medical Device 2020 conference. This was...
    Lupin Launches Authorized Generic version of Vimovo®  delayed-release tablets

    Lupin Launches Authorized Generic version of Vimovo® delayed-release tablets

    Medical Dialogues Bureau6 March 2020 5:30 AM GMT
    The product is a combination of naproxen, a non-steroidal anti-inflammatory drug (NSAID), and esomeprazole magnesium, a proton pump inhibitor (PPI)
    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Dr VG Somani DCGI releases IPA guidelines on Market Complaints.

    Medical Dialogues Bureau2 March 2020 5:00 AM GMT
    The guidelines were released at the recently concluded India Pharmaceutical Forum
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X